Dong Liu

Prof. Dr. Dong Liu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2025 in Foods
Verified
Journal Article
Open access
PDF file
Jingli WangJingli Wang
Jingli Wang
JCJieyu Chen
Jieyu Chen
MGMingkun Gao
Mingkun Gao
ZOZijun Ouyang
Zijun Ouyang
YLYanhui Li
Yanhui Li
HSHaiyan Sun
Haiyan Sun
Hyperlipidemia is one of the most prevalent metabolic disorders worldwide. It is a significant risk factor for a range of cardiovascular diseases, including acute pancreatitis, fatty liver disease, atherosclerosis, and coronary heart disease. In clinical practice, the management of hyperlipidemia is hindered by numerous challenges. One of the critical issues is that traditional lipid-lowering drugs often require long-term or even lifelong administration, potentially inducing a range of adverse effects that compromise patient compliance and therapeutic efficacy. Therefore, there is an urgent need to develop safer and more effective strategies for the prevention and adjunctive treatment of hyperlipidemia with the aim of reducing the risk of disease and over-reliance on medication. Recent studies have revealed a close relationship between hyperlipidemia and related metabolic disorders involving gut microbiota dysbiosis, and the administration of probiotics has been shown to improve lipid metabolism homeostasis. This review summarizes the molecular mechanisms of probiotics in hyperlipidemia treatment and the latest advances in probiotic research on lipid metabolism, enumerates the experimental and clinical applications of probiotic-based therapies, introduces methods for screening and identifying probiotics with lipid-lowering functions, and, for the first time, summarizes the roles of emerging technologies such as functional genomics and in vivo zebrafish-on-a-chip models in studying the lipid-lowering efficacy of probiotics, providing insights for researchers. By facilitating a deeper understanding of the mechanisms whereby probiotics reduce blood lipid levels and furthering the development of multifaceted screening methods, we hope that we can achieve high-throughput and efficient screening of probiotics with lipid-lowering functions, thereby promoting the sustainable, high-quality, and rapid development of the probiotics industry.

28 January 2025 in Food Bioscience
Verified
Journal Article
Closed access
QMQin Ma
Qin Ma
XWXin Wang
Xin Wang
RZRuifen Zhang
Ruifen Zhang
FHFei Huang
Fei Huang
XJXuchao Jia
Xuchao Jia
MZMingwei Zhang
Mingwei Zhang

15 February 2023 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
XZXinmiao Zhang
Xinmiao Zhang
DLDong Liu
Dong Liu
ZYZiyang Ye
Ziyang Ye
XCXue Chen
Xue Chen
Hui ChenHui Chen
Hui Chen
MYMing Ye
Ming Ye

19 February 2025 in Phytomedicine
Verified
Journal Article
Open access
WZWanjun Zhao
Wanjun Zhao
XLXiaoyan Liu
Xiaoyan Liu
JTJianing Tang
Jianing Tang
JCJieyu Chen
Jieyu Chen
DLDong Liu
Dong Liu
ZOZijun Ouyang
Zijun Ouyang
The underlying pathogenesis of psoriasis was attributed to insufficient kidney qi and blood stasis arising from impeded blood circulation. Jinkui Shenqi decoction (JKSQD), was renowned for its capacity to warm and tonify kidney yang, as well as to invigorate blood circulation. However, there remains a dearth of studies on its specific therapeutic effects and underlying mechanisms of psoriasis. Aiming to investigate the effectiveness and mechanism of JKSQD in the treatment of psoriasis. Initially, we identified the compounds of JKSQD by UPLC-Q-TOF-MS/MS and constructed psoriasis-like mice to explore the effect of JKSQD on psoriasis. Subsequently, proteomic sequencing was conducted to identify key proteins and pathways involved in the therapeutic effect of JKSQD. Neutrophil extracellular traps (NETs) and peptidylarginine deiminase 4 (PAD4)-related indicators were detected to validate JKSQD mechanisms. At last, we analyzed metabolomic data to elucidate what metabolic pathway or metabolites worked during this procedure. We found that JKSQD effectively reversed the progression of psoriasis and associated inflammation in mice. Proteomic analysis further illuminated that PAD4 involved in NETosis was notably downregulated in psoriasis-like mice after JKSQD treatment. And a series of experiments further revealed that JKSQD inhibited NETs formation and PAD4 expression. Moreover, metabolomics demonstrated JKSQD influenced D-Arginine and D-ornithine metabolism, offering deeper insights into the mechanisms of JKSQD on psoriasis. This study unveiled that JKSQD could improve psoriasis progression by targeting PAD4 to inhibit NETs formation.

11 November 2025 in Foods
Verified
Journal Article
Open access
PDF file
SLShuyu Li
Shuyu Li
YLYanhui Li
Yanhui Li
CXChunxu Xue
Chunxu Xue
YZYing Zhang
Ying Zhang
TTTong Tong
Tong Tong
HSHaiyan Sun
Haiyan Sun
Sleep disorders represent a growing global health concern with significant socio-economic impacts. GABA, a natural bioactive compound abundant in various fermented foods, especially probiotic-fermented foods, has garnered increasing attention for its potential to improve sleep quality. This review systematically elucidates the multi-pathway mechanisms by which GABA regulates sleep, focusing on (1) indirect modulation of central sleep–wake circuits via the gut–brain axis through vagal nerve, neuroendocrine, and immune pathways; (2) potential entry into the brain by leveraging the dynamic permeability of the blood–brain barrier (BBB) and transporter-mediated active transport; and (3) metabolic conversion into active substances like γ-hydroxybutyrate (GHB), which synergistically optimizes sleep architecture via multiple receptor systems and energy metabolism. Furthermore, we summarize the sleep-promoting effects of GABA-enriched foods observed in animal and clinical studies and discuss emerging applications, including high-GABA-yielding probiotics and personalized nutrition strategies for sleep intervention. This review provides a theoretical basis and innovative directions for the development of GABA-based functional foods and sleep health management.

5 September 2025 in Foods
Verified
Journal Article
Open access
PDF file
YCYanxia Chen
Yanxia Chen
QMQin Ma
Qin Ma
FHFei Huang
Fei Huang
XJXuchao Jia
Xuchao Jia
LDLihong Dong
Lihong Dong
RZRuifen Zhang
Ruifen Zhang
Rice bran represents an exceptional natural source of dietary fiber (DF), and its physicochemical properties and therapeutic potential are closely associated with its origin and processing methods. Herein, rice bran was subjected to extrusion, fermentation, and a combined treatment of fermentation and extrusion to explore the alternations in the structural, physicochemical, and functional properties of the resulting insoluble dietary fiber (IDF). All treatments induced substantial microstructural alterations in IDF, producing fiber matrices with enhanced porosity and looser architectures. The employed processing treatments significantly enhanced the functional properties of rice bran IDF over the unprocessed sample, with 1.37- to 1.78-fold increases in oil-holding capacity, 1.31- to 1.48-fold increases in cholesterol-adsorption capacity, 2.89- to 5.90-fold increases in α-amylase-inhibitory activity, and 2.41- to 3.70-fold increases in glucose-adsorption capacity. Among them, extrusion proved more effective than fermentation in enhancing the water-holding capacity, sodium cholate binding, and cholesterol-adsorption capacity of rice bran IDF. However, fermented rice bran-derived IDF exhibited the optimum α-amylase-inhibitory and glucose-absorption capacities among all employed IDF samples. These findings provide valuable insights for the development of rice bran-based functional foods with enhanced health benefits.